Pharma & Healthcare
Global Telmisartan Market Research Report 2024
- Jan 20, 24
- ID: 7723
- Pages: 96
- Figures: 200
- Views: 58
The global Telmisartan market was valued at US$ 3248.7 million in 2023 and is anticipated to reach US$ 3631.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Telmisartan include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telmisartan.
Report Scope
The Telmisartan market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Telmisartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Telmisartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Telmisartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Telmisartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Telmisartan include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telmisartan.
Report Scope
The Telmisartan market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Telmisartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Telmisartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Telmisartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Telmisartan Market Overview
1.1 Product Overview and Scope of Telmisartan
1.2 Telmisartan Segment by Type
1.2.1 Global Telmisartan Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Telmisartan Segment by Application
1.3.1 Global Telmisartan Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Telmisartan Market Size Estimates and Forecasts
1.4.1 Global Telmisartan Revenue 2019-2030
1.4.2 Global Telmisartan Sales 2019-2030
1.4.3 Global Telmisartan Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Telmisartan Market Competition by Manufacturers
2.1 Global Telmisartan Sales Market Share by Manufacturers (2019-2024)
2.2 Global Telmisartan Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Telmisartan Average Price by Manufacturers (2019-2024)
2.4 Global Telmisartan Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Telmisartan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Telmisartan, Product Type & Application
2.7 Telmisartan Market Competitive Situation and Trends
2.7.1 Telmisartan Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Telmisartan Players Market Share by Revenue
2.7.3 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Telmisartan Retrospective Market Scenario by Region
3.1 Global Telmisartan Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Telmisartan Global Telmisartan Sales by Region: 2019-2030
3.2.1 Global Telmisartan Sales by Region: 2019-2024
3.2.2 Global Telmisartan Sales by Region: 2025-2030
3.3 Global Telmisartan Global Telmisartan Revenue by Region: 2019-2030
3.3.1 Global Telmisartan Revenue by Region: 2019-2024
3.3.2 Global Telmisartan Revenue by Region: 2025-2030
3.4 North America Telmisartan Market Facts & Figures by Country
3.4.1 North America Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Telmisartan Sales by Country (2019-2030)
3.4.3 North America Telmisartan Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Telmisartan Market Facts & Figures by Country
3.5.1 Europe Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Telmisartan Sales by Country (2019-2030)
3.5.3 Europe Telmisartan Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Telmisartan Market Facts & Figures by Country
3.6.1 Asia Pacific Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Telmisartan Sales by Country (2019-2030)
3.6.3 Asia Pacific Telmisartan Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Telmisartan Market Facts & Figures by Country
3.7.1 Latin America Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Telmisartan Sales by Country (2019-2030)
3.7.3 Latin America Telmisartan Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Telmisartan Market Facts & Figures by Country
3.8.1 Middle East and Africa Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Telmisartan Sales by Country (2019-2030)
3.8.3 Middle East and Africa Telmisartan Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Telmisartan Sales by Type (2019-2030)
4.1.1 Global Telmisartan Sales by Type (2019-2024)
4.1.2 Global Telmisartan Sales by Type (2025-2030)
4.1.3 Global Telmisartan Sales Market Share by Type (2019-2030)
4.2 Global Telmisartan Revenue by Type (2019-2030)
4.2.1 Global Telmisartan Revenue by Type (2019-2024)
4.2.2 Global Telmisartan Revenue by Type (2025-2030)
4.2.3 Global Telmisartan Revenue Market Share by Type (2019-2030)
4.3 Global Telmisartan Price by Type (2019-2030)
5 Segment by Application
5.1 Global Telmisartan Sales by Application (2019-2030)
5.1.1 Global Telmisartan Sales by Application (2019-2024)
5.1.2 Global Telmisartan Sales by Application (2025-2030)
5.1.3 Global Telmisartan Sales Market Share by Application (2019-2030)
5.2 Global Telmisartan Revenue by Application (2019-2030)
5.2.1 Global Telmisartan Revenue by Application (2019-2024)
5.2.2 Global Telmisartan Revenue by Application (2025-2030)
5.2.3 Global Telmisartan Revenue Market Share by Application (2019-2030)
5.3 Global Telmisartan Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Telmisartan Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Telmisartan Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Telmisartan Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Telmisartan Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Telmisartan Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Reddy's Laboratories (UK)
6.6.1 Reddy's Laboratories (UK) Corporation Information
6.6.2 Reddy's Laboratories (UK) Description and Business Overview
6.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
6.6.5 Reddy's Laboratories (UK) Recent Developments/Updates
6.7 Hema Pharmaceuticals Pvt
6.6.1 Hema Pharmaceuticals Pvt Corporation Information
6.6.2 Hema Pharmaceuticals Pvt Description and Business Overview
6.6.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
6.7.5 Hema Pharmaceuticals Pvt Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Telmisartan Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Telmisartan Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Astellas Pharma Inc
6.10.1 Astellas Pharma Inc Corporation Information
6.10.2 Astellas Pharma Inc Description and Business Overview
6.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Astellas Pharma Inc Telmisartan Product Portfolio
6.10.5 Astellas Pharma Inc Recent Developments/Updates
6.11 Nippon Boehringer Ingelheim
6.11.1 Nippon Boehringer Ingelheim Corporation Information
6.11.2 Nippon Boehringer Ingelheim Telmisartan Description and Business Overview
6.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
6.11.5 Nippon Boehringer Ingelheim Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Telmisartan Description and Business Overview
6.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Telmisartan Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Telmisartan Description and Business Overview
6.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Takeda Telmisartan Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Beijing Wansheng Pharmaceutical
6.14.1 Beijing Wansheng Pharmaceutical Corporation Information
6.14.2 Beijing Wansheng Pharmaceutical Telmisartan Description and Business Overview
6.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
6.14.5 Beijing Wansheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Telmisartan Industry Chain Analysis
7.2 Telmisartan Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Telmisartan Production Mode & Process
7.4 Telmisartan Sales and Marketing
7.4.1 Telmisartan Sales Channels
7.4.2 Telmisartan Distributors
7.5 Telmisartan Customers
8 Telmisartan Market Dynamics
8.1 Telmisartan Industry Trends
8.2 Telmisartan Market Drivers
8.3 Telmisartan Market Challenges
8.4 Telmisartan Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Telmisartan
1.2 Telmisartan Segment by Type
1.2.1 Global Telmisartan Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Telmisartan Segment by Application
1.3.1 Global Telmisartan Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Telmisartan Market Size Estimates and Forecasts
1.4.1 Global Telmisartan Revenue 2019-2030
1.4.2 Global Telmisartan Sales 2019-2030
1.4.3 Global Telmisartan Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Telmisartan Market Competition by Manufacturers
2.1 Global Telmisartan Sales Market Share by Manufacturers (2019-2024)
2.2 Global Telmisartan Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Telmisartan Average Price by Manufacturers (2019-2024)
2.4 Global Telmisartan Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Telmisartan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Telmisartan, Product Type & Application
2.7 Telmisartan Market Competitive Situation and Trends
2.7.1 Telmisartan Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Telmisartan Players Market Share by Revenue
2.7.3 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Telmisartan Retrospective Market Scenario by Region
3.1 Global Telmisartan Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Telmisartan Global Telmisartan Sales by Region: 2019-2030
3.2.1 Global Telmisartan Sales by Region: 2019-2024
3.2.2 Global Telmisartan Sales by Region: 2025-2030
3.3 Global Telmisartan Global Telmisartan Revenue by Region: 2019-2030
3.3.1 Global Telmisartan Revenue by Region: 2019-2024
3.3.2 Global Telmisartan Revenue by Region: 2025-2030
3.4 North America Telmisartan Market Facts & Figures by Country
3.4.1 North America Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Telmisartan Sales by Country (2019-2030)
3.4.3 North America Telmisartan Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Telmisartan Market Facts & Figures by Country
3.5.1 Europe Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Telmisartan Sales by Country (2019-2030)
3.5.3 Europe Telmisartan Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Telmisartan Market Facts & Figures by Country
3.6.1 Asia Pacific Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Telmisartan Sales by Country (2019-2030)
3.6.3 Asia Pacific Telmisartan Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Telmisartan Market Facts & Figures by Country
3.7.1 Latin America Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Telmisartan Sales by Country (2019-2030)
3.7.3 Latin America Telmisartan Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Telmisartan Market Facts & Figures by Country
3.8.1 Middle East and Africa Telmisartan Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Telmisartan Sales by Country (2019-2030)
3.8.3 Middle East and Africa Telmisartan Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Telmisartan Sales by Type (2019-2030)
4.1.1 Global Telmisartan Sales by Type (2019-2024)
4.1.2 Global Telmisartan Sales by Type (2025-2030)
4.1.3 Global Telmisartan Sales Market Share by Type (2019-2030)
4.2 Global Telmisartan Revenue by Type (2019-2030)
4.2.1 Global Telmisartan Revenue by Type (2019-2024)
4.2.2 Global Telmisartan Revenue by Type (2025-2030)
4.2.3 Global Telmisartan Revenue Market Share by Type (2019-2030)
4.3 Global Telmisartan Price by Type (2019-2030)
5 Segment by Application
5.1 Global Telmisartan Sales by Application (2019-2030)
5.1.1 Global Telmisartan Sales by Application (2019-2024)
5.1.2 Global Telmisartan Sales by Application (2025-2030)
5.1.3 Global Telmisartan Sales Market Share by Application (2019-2030)
5.2 Global Telmisartan Revenue by Application (2019-2030)
5.2.1 Global Telmisartan Revenue by Application (2019-2024)
5.2.2 Global Telmisartan Revenue by Application (2025-2030)
5.2.3 Global Telmisartan Revenue Market Share by Application (2019-2030)
5.3 Global Telmisartan Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Telmisartan Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Telmisartan Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Telmisartan Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Telmisartan Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Telmisartan Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Reddy's Laboratories (UK)
6.6.1 Reddy's Laboratories (UK) Corporation Information
6.6.2 Reddy's Laboratories (UK) Description and Business Overview
6.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
6.6.5 Reddy's Laboratories (UK) Recent Developments/Updates
6.7 Hema Pharmaceuticals Pvt
6.6.1 Hema Pharmaceuticals Pvt Corporation Information
6.6.2 Hema Pharmaceuticals Pvt Description and Business Overview
6.6.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
6.7.5 Hema Pharmaceuticals Pvt Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Telmisartan Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Telmisartan Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Astellas Pharma Inc
6.10.1 Astellas Pharma Inc Corporation Information
6.10.2 Astellas Pharma Inc Description and Business Overview
6.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Astellas Pharma Inc Telmisartan Product Portfolio
6.10.5 Astellas Pharma Inc Recent Developments/Updates
6.11 Nippon Boehringer Ingelheim
6.11.1 Nippon Boehringer Ingelheim Corporation Information
6.11.2 Nippon Boehringer Ingelheim Telmisartan Description and Business Overview
6.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
6.11.5 Nippon Boehringer Ingelheim Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Telmisartan Description and Business Overview
6.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Telmisartan Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Telmisartan Description and Business Overview
6.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Takeda Telmisartan Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Beijing Wansheng Pharmaceutical
6.14.1 Beijing Wansheng Pharmaceutical Corporation Information
6.14.2 Beijing Wansheng Pharmaceutical Telmisartan Description and Business Overview
6.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
6.14.5 Beijing Wansheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Telmisartan Industry Chain Analysis
7.2 Telmisartan Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Telmisartan Production Mode & Process
7.4 Telmisartan Sales and Marketing
7.4.1 Telmisartan Sales Channels
7.4.2 Telmisartan Distributors
7.5 Telmisartan Customers
8 Telmisartan Market Dynamics
8.1 Telmisartan Industry Trends
8.2 Telmisartan Market Drivers
8.3 Telmisartan Market Challenges
8.4 Telmisartan Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Telmisartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Telmisartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Telmisartan Market Competitive Situation by Manufacturers in 2023
Table 4. Global Telmisartan Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Telmisartan Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Telmisartan Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Telmisartan Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Telmisartan Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Telmisartan, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Telmisartan, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Telmisartan, Product Type & Application
Table 12. Global Key Manufacturers of Telmisartan, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Telmisartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telmisartan as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Telmisartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Telmisartan Sales by Region (2019-2024) & (MT)
Table 18. Global Telmisartan Sales Market Share by Region (2019-2024)
Table 19. Global Telmisartan Sales by Region (2025-2030) & (MT)
Table 20. Global Telmisartan Sales Market Share by Region (2025-2030)
Table 21. Global Telmisartan Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Telmisartan Revenue Market Share by Region (2019-2024)
Table 23. Global Telmisartan Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Telmisartan Revenue Market Share by Region (2025-2030)
Table 25. North America Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Telmisartan Sales by Country (2019-2024) & (MT)
Table 27. North America Telmisartan Sales by Country (2025-2030) & (MT)
Table 28. North America Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Telmisartan Sales by Country (2019-2024) & (MT)
Table 32. Europe Telmisartan Sales by Country (2025-2030) & (MT)
Table 33. Europe Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Telmisartan Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Telmisartan Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Telmisartan Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Telmisartan Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Telmisartan Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Telmisartan Sales by Country (2019-2024) & (MT)
Table 42. Latin America Telmisartan Sales by Country (2025-2030) & (MT)
Table 43. Latin America Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Telmisartan Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Telmisartan Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Telmisartan Sales (MT) by Type (2019-2024)
Table 51. Global Telmisartan Sales (MT) by Type (2025-2030)
Table 52. Global Telmisartan Sales Market Share by Type (2019-2024)
Table 53. Global Telmisartan Sales Market Share by Type (2025-2030)
Table 54. Global Telmisartan Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Telmisartan Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Telmisartan Revenue Market Share by Type (2019-2024)
Table 57. Global Telmisartan Revenue Market Share by Type (2025-2030)
Table 58. Global Telmisartan Price (USD/Kg) by Type (2019-2024)
Table 59. Global Telmisartan Price (USD/Kg) by Type (2025-2030)
Table 60. Global Telmisartan Sales (MT) by Application (2019-2024)
Table 61. Global Telmisartan Sales (MT) by Application (2025-2030)
Table 62. Global Telmisartan Sales Market Share by Application (2019-2024)
Table 63. Global Telmisartan Sales Market Share by Application (2025-2030)
Table 64. Global Telmisartan Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Telmisartan Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Telmisartan Revenue Market Share by Application (2019-2024)
Table 67. Global Telmisartan Revenue Market Share by Application (2025-2030)
Table 68. Global Telmisartan Price (USD/Kg) by Application (2019-2024)
Table 69. Global Telmisartan Price (USD/Kg) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Pfizer Telmisartan Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Teva Telmisartan Product
Table 79. Teva Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Telmisartan Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Novartis Telmisartan Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Mylan Telmisartan Product
Table 94. Mylan Recent Developments/Updates
Table 95. Reddy's Laboratories (UK) Corporation Information
Table 96. Reddy's Laboratories (UK) Description and Business Overview
Table 97. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Reddy's Laboratories (UK) Telmisartan Product
Table 99. Reddy's Laboratories (UK) Recent Developments/Updates
Table 100. Hema Pharmaceuticals Pvt Corporation Information
Table 101. Hema Pharmaceuticals Pvt Description and Business Overview
Table 102. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Hema Pharmaceuticals Pvt Telmisartan Product
Table 104. Hema Pharmaceuticals Pvt Recent Developments/Updates
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Bayer Telmisartan Product
Table 109. Bayer Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 113. GSK Telmisartan Product
Table 114. GSK Recent Developments/Updates
Table 115. Astellas Pharma Inc Corporation Information
Table 116. Astellas Pharma Inc Description and Business Overview
Table 117. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 118. Astellas Pharma Inc Telmisartan Product
Table 119. Astellas Pharma Inc Recent Developments/Updates
Table 120. Nippon Boehringer Ingelheim Corporation Information
Table 121. Nippon Boehringer Ingelheim Description and Business Overview
Table 122. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 123. Nippon Boehringer Ingelheim Telmisartan Product
Table 124. Nippon Boehringer Ingelheim Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 128. Abbott Telmisartan Product
Table 129. Abbott Recent Developments/Updates
Table 130. Takeda Corporation Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 133. Takeda Telmisartan Product
Table 134. Takeda Recent Developments/Updates
Table 135. Beijing Wansheng Pharmaceutical Corporation Information
Table 136. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 137. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 138. Beijing Wansheng Pharmaceutical Telmisartan Product
Table 139. Beijing Wansheng Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Telmisartan Distributors List
Table 143. Telmisartan Customers List
Table 144. Telmisartan Market Trends
Table 145. Telmisartan Market Drivers
Table 146. Telmisartan Market Challenges
Table 147. Telmisartan Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Telmisartan
Figure 2. Global Telmisartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Telmisartan Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Freeze-Dried Powder Product Picture
Figure 6. Global Telmisartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Telmisartan Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Telmisartan Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Telmisartan Market Size (2019-2030) & (US$ Million)
Figure 13. Global Telmisartan Sales (2019-2030) & (MT)
Figure 14. Global Telmisartan Average Price (USD/Kg) & (2019-2030)
Figure 15. Telmisartan Report Years Considered
Figure 16. Telmisartan Sales Share by Manufacturers in 2023
Figure 17. Global Telmisartan Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Telmisartan Players: Market Share by Revenue in 2023
Figure 19. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Telmisartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Telmisartan Sales Market Share by Country (2019-2030)
Figure 22. North America Telmisartan Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Telmisartan Sales Market Share by Country (2019-2030)
Figure 26. Europe Telmisartan Revenue Market Share by Country (2019-2030)
Figure 27. Germany Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Telmisartan Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Telmisartan Revenue Market Share by Region (2019-2030)
Figure 34. China Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Telmisartan Sales Market Share by Country (2019-2030)
Figure 45. Latin America Telmisartan Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Telmisartan Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Telmisartan Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Telmisartan by Type (2019-2030)
Figure 55. Global Revenue Market Share of Telmisartan by Type (2019-2030)
Figure 56. Global Telmisartan Price (USD/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Telmisartan by Application (2019-2030)
Figure 58. Global Revenue Market Share of Telmisartan by Application (2019-2030)
Figure 59. Global Telmisartan Price (USD/Kg) by Application (2019-2030)
Figure 60. Telmisartan Value Chain
Figure 61. Telmisartan Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Telmisartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Telmisartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Telmisartan Market Competitive Situation by Manufacturers in 2023
Table 4. Global Telmisartan Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Telmisartan Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Telmisartan Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Telmisartan Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Telmisartan Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Telmisartan, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Telmisartan, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Telmisartan, Product Type & Application
Table 12. Global Key Manufacturers of Telmisartan, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Telmisartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telmisartan as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Telmisartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Telmisartan Sales by Region (2019-2024) & (MT)
Table 18. Global Telmisartan Sales Market Share by Region (2019-2024)
Table 19. Global Telmisartan Sales by Region (2025-2030) & (MT)
Table 20. Global Telmisartan Sales Market Share by Region (2025-2030)
Table 21. Global Telmisartan Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Telmisartan Revenue Market Share by Region (2019-2024)
Table 23. Global Telmisartan Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Telmisartan Revenue Market Share by Region (2025-2030)
Table 25. North America Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Telmisartan Sales by Country (2019-2024) & (MT)
Table 27. North America Telmisartan Sales by Country (2025-2030) & (MT)
Table 28. North America Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Telmisartan Sales by Country (2019-2024) & (MT)
Table 32. Europe Telmisartan Sales by Country (2025-2030) & (MT)
Table 33. Europe Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Telmisartan Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Telmisartan Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Telmisartan Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Telmisartan Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Telmisartan Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Telmisartan Sales by Country (2019-2024) & (MT)
Table 42. Latin America Telmisartan Sales by Country (2025-2030) & (MT)
Table 43. Latin America Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Telmisartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Telmisartan Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Telmisartan Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Telmisartan Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Telmisartan Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Telmisartan Sales (MT) by Type (2019-2024)
Table 51. Global Telmisartan Sales (MT) by Type (2025-2030)
Table 52. Global Telmisartan Sales Market Share by Type (2019-2024)
Table 53. Global Telmisartan Sales Market Share by Type (2025-2030)
Table 54. Global Telmisartan Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Telmisartan Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Telmisartan Revenue Market Share by Type (2019-2024)
Table 57. Global Telmisartan Revenue Market Share by Type (2025-2030)
Table 58. Global Telmisartan Price (USD/Kg) by Type (2019-2024)
Table 59. Global Telmisartan Price (USD/Kg) by Type (2025-2030)
Table 60. Global Telmisartan Sales (MT) by Application (2019-2024)
Table 61. Global Telmisartan Sales (MT) by Application (2025-2030)
Table 62. Global Telmisartan Sales Market Share by Application (2019-2024)
Table 63. Global Telmisartan Sales Market Share by Application (2025-2030)
Table 64. Global Telmisartan Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Telmisartan Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Telmisartan Revenue Market Share by Application (2019-2024)
Table 67. Global Telmisartan Revenue Market Share by Application (2025-2030)
Table 68. Global Telmisartan Price (USD/Kg) by Application (2019-2024)
Table 69. Global Telmisartan Price (USD/Kg) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Pfizer Telmisartan Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Teva Telmisartan Product
Table 79. Teva Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Telmisartan Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Novartis Telmisartan Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Mylan Telmisartan Product
Table 94. Mylan Recent Developments/Updates
Table 95. Reddy's Laboratories (UK) Corporation Information
Table 96. Reddy's Laboratories (UK) Description and Business Overview
Table 97. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Reddy's Laboratories (UK) Telmisartan Product
Table 99. Reddy's Laboratories (UK) Recent Developments/Updates
Table 100. Hema Pharmaceuticals Pvt Corporation Information
Table 101. Hema Pharmaceuticals Pvt Description and Business Overview
Table 102. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Hema Pharmaceuticals Pvt Telmisartan Product
Table 104. Hema Pharmaceuticals Pvt Recent Developments/Updates
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Bayer Telmisartan Product
Table 109. Bayer Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 113. GSK Telmisartan Product
Table 114. GSK Recent Developments/Updates
Table 115. Astellas Pharma Inc Corporation Information
Table 116. Astellas Pharma Inc Description and Business Overview
Table 117. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 118. Astellas Pharma Inc Telmisartan Product
Table 119. Astellas Pharma Inc Recent Developments/Updates
Table 120. Nippon Boehringer Ingelheim Corporation Information
Table 121. Nippon Boehringer Ingelheim Description and Business Overview
Table 122. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 123. Nippon Boehringer Ingelheim Telmisartan Product
Table 124. Nippon Boehringer Ingelheim Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 128. Abbott Telmisartan Product
Table 129. Abbott Recent Developments/Updates
Table 130. Takeda Corporation Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 133. Takeda Telmisartan Product
Table 134. Takeda Recent Developments/Updates
Table 135. Beijing Wansheng Pharmaceutical Corporation Information
Table 136. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 137. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 138. Beijing Wansheng Pharmaceutical Telmisartan Product
Table 139. Beijing Wansheng Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Telmisartan Distributors List
Table 143. Telmisartan Customers List
Table 144. Telmisartan Market Trends
Table 145. Telmisartan Market Drivers
Table 146. Telmisartan Market Challenges
Table 147. Telmisartan Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Telmisartan
Figure 2. Global Telmisartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Telmisartan Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Freeze-Dried Powder Product Picture
Figure 6. Global Telmisartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Telmisartan Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Telmisartan Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Telmisartan Market Size (2019-2030) & (US$ Million)
Figure 13. Global Telmisartan Sales (2019-2030) & (MT)
Figure 14. Global Telmisartan Average Price (USD/Kg) & (2019-2030)
Figure 15. Telmisartan Report Years Considered
Figure 16. Telmisartan Sales Share by Manufacturers in 2023
Figure 17. Global Telmisartan Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Telmisartan Players: Market Share by Revenue in 2023
Figure 19. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Telmisartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Telmisartan Sales Market Share by Country (2019-2030)
Figure 22. North America Telmisartan Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Telmisartan Sales Market Share by Country (2019-2030)
Figure 26. Europe Telmisartan Revenue Market Share by Country (2019-2030)
Figure 27. Germany Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Telmisartan Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Telmisartan Revenue Market Share by Region (2019-2030)
Figure 34. China Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Telmisartan Sales Market Share by Country (2019-2030)
Figure 45. Latin America Telmisartan Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Telmisartan Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Telmisartan Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Telmisartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Telmisartan by Type (2019-2030)
Figure 55. Global Revenue Market Share of Telmisartan by Type (2019-2030)
Figure 56. Global Telmisartan Price (USD/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Telmisartan by Application (2019-2030)
Figure 58. Global Revenue Market Share of Telmisartan by Application (2019-2030)
Figure 59. Global Telmisartan Price (USD/Kg) by Application (2019-2030)
Figure 60. Telmisartan Value Chain
Figure 61. Telmisartan Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232